SEVERE HEMOLYTIC UREMIC SYNDROME IN AN ADVANCED OVARIAN CANCER PATIENT TREATED WITH CARBOPLATIN AND GEMCITABINE

Hemolytic uremic syndrome (HUS) is a rare clinical and biological entity. HUS has been reported after several anticancer chemotherapies and most often after mitomycin C-based chemotherapy regimens. Little information is available concerning the occurrence and outcome of this syndrome after administr